REPORTS

ASCO20 this year ASCO was held virtually – despite this the studies presented did not disappoint. practice changing data that will alter standards of care in metastatic colorectal cancer, breast cancer and breast cancer was presented – as well as new treatment paradigms for early stage lung cancer.

ASCO20

delivering innovative cancer medicines in a modern healthcare system is a daunting challenge for canadians. the introduction of CAR T cell therapy brings with it an enormous amount of complexity for our systems. building strong partnerships to establish canada’s viability as a healthcare innovator, as a partner in delivering exceptional patient care, and a pioneer in healthcare policy that engages with stakeholders throughout the process is at a critical standpoint and we must work together to accelerate adoption of CAR T today and to deliver the medicines of tomorrow.

CART. accelerating adoption through collaboration

 

CHICAGO- caring for every patient. learning from every patient

the theme of this year’s ASCO meeting is intended to drive home the message that every patient deserves equal access to the highest quality care and the opportunity to participate in research, and not just some patients but EVERY patient- and to make sure that we, as clinicians, decision makers, payors, advocates and manufacturers use every single opportunity to do better until suffering from cancer is no longer part of our world.

the only way to truly learn from every patient is to engage with patients and each and every encounter with a patient is an opportunity to think about the different interventions, the different services that are necessary and the opportunity to think about how we can do this better for patients, for their families for healthcare systems and ultimately for society.

the ASCO theme should get everyone asking themselves how can we improve patient | scientist | clinician | decision maker collaboration and not only asking how can we learn from every patient, but how do we then translate these learnings so that we can make the greatest impact for patients from improving quality of life, to survivorship, better drug development, better decision making and finally even a cure?

ASCO 2019 Summary Report Final [EN]

CHICAGO- caring for every patient. learning from every patient

the theme of this year’s ASCO meeting is intended to drive home the message that every patient deserves equal access to the highest quality care and the opportunity to participate in research, and not just some patients but EVERY patient- and to make sure that we, as clinicians, decision makers, payors, advocates and manufacturers use every single opportunity to do better until suffering from cancer is no longer part of our world.

the only way to truly learn from every patient is to engage with patients and each and every encounter with a patient is an opportunity to think about the different interventions, the different services that are necessary and the opportunity to think about how we can do this better for patients, for their families for healthcare systems and ultimately for society.

the ASCO theme should get everyone asking themselves how can we improve patient | scientist | clinician | decision maker collaboration and not only asking how can we learn from every patient, but how do we then translate these learnings so that we can make the greatest impact for patients from improving quality of life, to survivorship, better drug development, better decision making and finally even a cure?

download the  ASCO 2019 report [pdf EN]

car t-cell therapy is a remarkable technical advancement in scientific progress on how we treat cancer, especially in that in addresses a very unmet need in a specific population. this approach is just the cusp of how we can use the immune system to treat cancer and can be expanded to cure more patients in more indications earlier in the treatment paradigm, but only if we are able to maximize the potential of this exciting advancement now. throughout our discussion, several overarching themes were repeatedly brought up.

colab.brief PDF download [EN]

implementing an oncology biosimilars strategy that improves outcomes for patients, is evidenced informed, ensures appropriate quality and safety measures are in place, and facilitates access to innovative cancer treatments

november 2018

biosimilarreport

CHICAGO- once again the american society for clinical oncology [ASCO] featured the latest news, information and data about advances in clinical cancer, however the program context also reflected a desire to broaden the reach of those advances and ensure the maximum number of patients derive maximum benefit. a substantial portion of the program was devoted to issues such as access to care; social, economic, and clinical disparities; use of technology to broaden the reach of cancer care and make it more efficient; greater emphasis on patient-reported outcomes and shared decision-making; and caring for the growing population of cancer survivors.

led by ASCO president bruce johnson, a cancer survivor himself, the working theme for the 54th annual, meeting delivering discoveries: expanding the reach of precision medicine – the studies presented at ASCO have real and life-changing effects for people with cancer today and tomorrow. “the promise of precision medicine is only as good as our ability to make these treatments available to all patients,” said dr. johnson during his presidential address.

download the  ASCO 2018 report [pdf EN]
télécharger le rapport ASCO 2018 [pdf FR]